-
3-(3-(tert-Butylthio)-1-(4-chlorobenzyl)-5-isopropyl-1H-indol-2-yl)-2,2-dimethylpropanoic acid
-
BD267012118414-82-798%
-
¥1005.0100mg
-
1-(4-(Benzo[d]thiazol-2-ylmethoxy)-2-methylphenyl)-3-(3,4-dichlorophenyl)urea
-
BD01307321724453-98-997%
-
¥374.025mg
-
3'-((3-Hydroxy-2,4-dioxo-3,4-dihydrothieno[3,2-d]pyrimidin-1(2H)-yl)methyl)-[1,1'-biphenyl]-4-carboxamide
-
BD01483374824983-94-098%
-
¥6791.0100mg
-
3-Hydroxy-1-((7-methoxybenzo[d][1,3]dioxol-5-yl)methyl)-5-methylthieno[2,3-d]pyrimidine-2,4(1H,3H)-dione
-
BD517911824983-90-697%
-
¥
-
Quiflapon sodium
-
BD630318147030-01-198+%
-
¥4696.010mg
-
Sodium 3-(3-(tert-butylthio)-1-(4-chlorobenzyl)-5-isopropyl-1H-indol-2-yl)-2,2-dimethylpropanoate
-
BD140210118427-55-798%
-
¥
-
Sodium 3-(3-(tert-butylthio)-1-(4-(6-ethoxypyridin-3-yl)benzyl)-5-((5-methylpyridin-2-yl)methoxy)-1H-indol-2-yl)-2,2-dimethylpropanoate
-
BD6299751196070-26-498+%
-
¥2769.010mg
-
3-(2,4-Dihydroxybenzylidene)-5-(4-methoxyphenyl)furan-2(3H)-one
-
BD6471866621-92-797%
-
¥
-
ALR-27
-
BD02515514903639-13-498%
-
¥
-
Sodium 3-(3-(tert-butylthio)-1-(4-(6-methoxypyridin-3-yl)benzyl)-5-(pyridin-2-ylmethoxy)-1H-indol-2-yl)-2,2-dimethylpropanoate
-
BD7664521147872-22-798+%
-
¥
-
(1R,2R)-2-(4-(5-Methyl-1H-pyrazol-3-yl)benzoyl)-N-(4-oxo-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrazin-3-yl)cyclohexane-1-carboxamide
-
BD014207112041075-86-795%
-
¥5495.010mg
-
FEN1-IN-5
-
BD02155627824983-93-998%
-
¥
-
(S)-Veliflapon
-
BD01854240128253-32-798%
-
¥
-
(S)-BI 665915
-
BD012956451360550-05-598%
-
¥
-
FEN1-IN-6
-
BD02183331824983-84-898%
-
¥
-
3-(3-(tert-Butylthio)-1-(4-(6-ethoxypyridin-3-yl)benzyl)-5-((5-methylpyridin-2-yl)methoxy)-1H-indol-2-yl)-2,2-dimethylpropanoic acid
-
BD631035936350-00-498%
-
¥1661.05mg
-
2-Cyclopentyl-2-(2-((4-formylquinolin-2-yl)methoxy)phenyl)acetic acid
-
BD702224128253-31-697%
-
¥37843.0100mg